18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma

NCT03051555 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Extranodal NK-T-Cell

Interventions

DEVICE: 18F-FDG PET/ CT

Sponsor

Peking University Cancer Hospital & Institute

Collaborators

[object Object]